PRESS RELEASE published on 12/17/2024 at 18:00, 1 year 4 months ago THERANEXUS AND EXELTIS (INSUD PHARMA) ANNOUNCE LICENSING AGREEMENT TO COMMERCIALIZE THERANEXUS TX01 FOR TWO RARE NEUROLOGICAL DISORDERS Theranexus and Exeltis sign license agreement for TX01, expanding treatment for rare neurological diseases. Exeltis to market TX01 across Europe and other regions License Agreement Theranexus Neurological Diseases Exeltis TX01
BRIEF published on 11/19/2024 at 18:05, 1 year 5 months ago Theranexus présente des résultats positifs pour le traitement de la maladie de Batten CLN3 Essai Clinique Theranexus Batten-1 Maladie De Batten Acuité Visuelle
BRIEF published on 11/19/2024 at 18:05, 1 year 5 months ago Theranexus presents positive results for the treatment of Batten disease CLN3 Clinical Trial Theranexus Batten-1 Batten Disease Visual Acuity
PRESS RELEASE published on 11/19/2024 at 18:00, 1 year 5 months ago Theranexus fait le point sur son programme Batten-1 dans la maladie de Batten CLN3 Présentation des résultats prometteurs de l'essai de phase I/II de Batten-1 par Theranexus et BBDF lors du Child Neurology Society Annual Meeting. Signaux positifs sur l'acuité visuelle de patients atteints de CLN3 Essai Clinique Theranexus Maladie De Batten CLN3 BBDF Acuité Visuelle
PRESS RELEASE published on 11/19/2024 at 18:00, 1 year 5 months ago Update on the Theranexus' Batten-1 project in CLN3 Batten's disease Theranexus and BBDF present positive results of Batten-1 trial in CLN3 Batten disease patients, showing safety and efficacy of miglustat. Expanded use indicates potential in visual acuity stabilization Theranexus BBDF Batten-1 Trial CLN3 Batten Disease Miglustat
BRIEF published on 10/23/2024 at 18:05, 1 year 6 months ago Theranexus Annonce Sa Trésorerie au 30 Septembre 2024 Trésorerie Maladie De Batten Partenariats Industriels Miglustat Crédit Impôt Recherche
BRIEF published on 10/23/2024 at 18:05, 1 year 6 months ago Theranexus Announces Its Cash Position as of September 30, 2024 Treasury Batten Disease Miglustat Research Tax Credit Industrial Partnerships
PRESS RELEASE published on 10/23/2024 at 18:00, 1 year 6 months ago THERANEXUS PUBLIE SA POSITION DE TRÉSORERIE AU 30 SEPTEMBRE 2024 Theranexus annonce sa trésorerie au 30 septembre 2024 avec 1,9 M€ disponible, incluant le Crédit Impôt Recherche de 785 K€. Projet d'enregistrement en Europe et phase 3 dans la maladie de Batten Trésorerie Phase 3 Theranexus Maladies Neurologiques CIR
PRESS RELEASE published on 10/23/2024 at 18:00, 1 year 6 months ago THERANEXUS ANNOUNCES ITS CASH POSITION AS OF SEPTEMBER 30, 2024 Theranexus reports €1.9 million cash position as of September 30, 2024, with plans for product registrations and phase 3 trials in rare neurological diseases Cash Position Biopharmaceutical Theranexus Rare Neurological Diseases Product Registrations
BRIEF published on 10/17/2024 at 18:05, 1 year 6 months ago Theranexus s'associe à Synerlab pour une avancée dans le traitement de Niemann-Pick C Theranexus EMA Synerlab Miglustat Niemann-Pick C
Published on 05/07/2026 at 02:00, 3 hours 22 minutes ago Lobe Sciences Ltd. Announces Participation in the D. Boral Capital Global Conference in New York
Published on 05/06/2026 at 23:30, 5 hours 52 minutes ago Stabilis Solutions Announces First Quarter 2026 Results
Published on 05/06/2026 at 23:05, 6 hours 17 minutes ago Zomedica Announces Record First Quarter Revenue of $8.8 Million, Reflecting 35% Annual Growth; and $47.5 Million in Liquidity
Published on 05/06/2026 at 23:00, 6 hours 22 minutes ago Green Bridge Metals Strengthens Technical and Strategic Team as 2026 Work Programs Advance
Published on 05/06/2026 at 22:10, 7 hours 12 minutes ago Banyan Gold Announces Closing of $46.5 Million Private Placement
Published on 05/07/2026 at 04:00, 1 hour 22 minutes ago L’Université chinoise de Hong Kong (CUHK) se classe en tête à Hong Kong et en Asie dans le dernier classement mondial des universités par discipline publié par QS (Quacquarelli Symonds)
Published on 05/07/2026 at 04:00, 1 hour 22 minutes ago CUHK Claims Top Positions in Hong Kong and Asia in the Latest QS World University Rankings by Subject
Published on 05/07/2026 at 03:50, 1 hour 31 minutes ago 450 MHz LTE: Stronger, Smarter Grid for Brazil
Published on 05/07/2026 at 00:47, 4 hours 35 minutes ago Blue Cap AG expands portfolio through the acquisition of Janoschka AG
Published on 05/07/2026 at 00:43, 4 hours 38 minutes ago EQS-Adhoc: Blue Cap AG Acquires Janoschka AG and Adjusts Forecast Due to Transaction
Published on 05/06/2026 at 18:00, 11 hours 22 minutes ago Mise à disposition des documents relatifs à l'AG du 4 juin 2026
Published on 05/06/2026 at 18:00, 11 hours 22 minutes ago Access to information in respect of the General Shareholders’ Meeting to be held on June 4, 2026
Published on 05/06/2026 at 18:00, 11 hours 22 minutes ago Information concerning the total number of voting rights and shares in the share capital as of April 30, 2026
Published on 05/06/2026 at 18:00, 11 hours 22 minutes ago Informations relatives au nombre total de droits de vote et d’actions composant le capital social au 30 avril 2026
Published on 05/06/2026 at 17:45, 11 hours 37 minutes ago Information concerning the total number of voting rights and shares 2026 04 30